November 17 (SeeNews) - Slovenian pharmaceutical products wholesaler Salus [LJE:SALR] said on Wednesday its consolidated net profit soared 52.9% to 10.4 million euro ($11.8 million) in the first nine months of 2021.
Consolidated net sales revenue went up by an annual 13% to 330 million euro in the first nine months of 2021, Salus said in a filing with the Ljubljana Stock Exchange.
The company's operating profit rose to 13.1 million euro from 8.6 million euro, while EBITDA grew to 15.3 million euro from 6.8 million euro, Salus said.
Ljubljana-based Salus is one of Slovenia's leading wholesalers of pharmaceutical and medical products.
($ = 0.88388 euro)